Insight on US FDA approval of Myfembree OD treatment for management of heavy menstrual bleeding associated with uterine fibroids
Myovant Sciences and Pfizer announced that the US Food and Drug Administration (FDA) has approved Myfembree (relugolix 40 mg, estradiol 1 mg,... Read More